Personal information

Activities

Employment (3)

University of Washington: Seattle, WA, US

2020-06-22 to present | PhD student (Comparative Health Outcomes, Policy, and Economics (CHOICE))
Employment
Source: Self-asserted source
Zizi Elsisi

University of Cincinnati: Cincinnati, OH, US

2018-08-28 to 2020-06-18 | Master's student (School of Pharmacy)
Employment
Source: Self-asserted source
Zizi Elsisi

Cairo University: Giza, EG

2014-09 to 2018-07 | Teaching and Research Assistant (Clinical Pharmacy)
Employment
Source: Self-asserted source
Zizi Elsisi

Education and qualifications (3)

University of Washington: Seattle, WA, US

2020-06 to 2025 | PhD in Health Economics and Outcomes research (HEOR) (Comparative Health Outcomes, Policy, and Economics (CHOICE))
Education
Source: Self-asserted source
Zizi Elsisi

University of Cincinnati: Cincinnati, Ohio, US

2018-08 to 2020-04 | MS in Health Outcomes (James L Winkle College of Pharmacy)
Education
Source: Self-asserted source
Zizi Elsisi

Cairo University Faculty of Pharmacy: Cairo, EG

2009-09-15 to 2014-05-15 | Bsc. of Pharmaceutical Sciences and Clinical Pharmacy. (Clinical Pharmacy and Pharmacy Practice department)
Education
Source: Self-asserted source
Zizi Elsisi

Professional activities (2)

International Society for Pharmacoeconomics and Outcomes Research: Lawrenceville, NJ, US

Student
Membership
Source: Self-asserted source
Zizi Elsisi

United States Bureau of Educational and Cultural Affairs Fulbright Program: Washington, DC, US

2018 | Foreign student Master's Program
Distinction
Source: Self-asserted source
Zizi Elsisi

Works (9)

Does real option value influence oncologists’ treatment recommendations? A survey of U.S. oncologists

Value in Health
2024-08 | Journal article
Part of ISSN: 1098-3015
Contributors: Meng Li; Zizi Elsisi; William Wong; Stacey Kowal; David L. Veenstra; Louis P. Garrison
Source: Self-asserted source
Zizi Elsisi

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019

Value in Health
2024-08 | Journal article
Part of ISSN: 1098-3015
Contributors: Louis P. Garrison; Boshen Jiao; Zizi Elsisi; Alon Yehoshua; Roy Koruth; Bruce Kreter; Jens Grueger
Source: Self-asserted source
Zizi Elsisi

Deprescribing interventions in older adults: An overview of systematic reviews

PLOS ONE
2024-06-17 | Journal article
Part of ISSN: 1932-6203
Contributors: Shiyun Chua; Adam Todd; Emily Reeve; Susan M. Smith; Julia Fox; Zizi Elsisi; Stephen Hughes; Andrew Husband; Aili Langford; Niamh A. Merriman et al.
Source: Self-asserted source
Zizi Elsisi

Geographic disparity in the distribution of cancer clinical trials in the United States and the associated factors

Journal of Managed Care & Specialty Pharmacy
2024-04 | Journal article
Part of ISSN: 2376-0540
Part of ISSN: 2376-1032
Contributors: Ningzhou Gu; Zizi Elsisi; Ryan Suk; Meng Li
Source: Self-asserted source
Zizi Elsisi

Effectiveness of Deprescribing Interventions in Older Adults: An Overview of Systematic Reviews

Research Square
2022 | Other
EID:

2-s2.0-85163252310

Contributors: Chua, S.; Todd, A.; Reeve, E.; Smith, S.M.; Elsisi, Z.; Hughes, S.; Husband, A.; Huang, Y.; Harris, J.R.; Devine, B. et al.
Source: Self-asserted source
Zizi Elsisi via Scopus - Elsevier

How Much Does the US Public Value Equity in Health? A Systematic Review

Value in Health
2022-10 | Journal article
Part of ISSN: 1098-3015
Contributors: Sara Khor; Zizi Elsisi; Josh J. Carlson
Source: Self-asserted source
Zizi Elsisi
grade
Preferred source (of 2)‎

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.

PharmacoEconomics - open
2022-04 | Journal article
Contributors: Baldwin Z; Jiao B; Basu A; Roth J; Bender MA; Elsisi Z; Johnson KM; Cousin E; Ramsey SD; Devine B
Source: Self-asserted source
Zizi Elsisi via Europe PubMed Central
grade
Preferred source (of 2)‎

Interventions to Reduce Fall-Risk-Increasing Drug Use to Prevent Falls: A Narrative Review of Randomized Trials.

Drugs & aging
2021-02 | Journal article
Contributors: Gray SL; Elsisi Z; Phelan EA; Hanlon JT
Source: Self-asserted source
Zizi Elsisi via Europe PubMed Central
grade
Preferred source (of 2)‎

Expenditure, Utilization, and Cost of Specialty Drugs for Multiple Sclerosis in the US Medicaid Population, 2008-2018.

American health & drug benefits
2020-05 | Journal article
Contributors: Elsisi Z; Hincapie AL; Guo JJ
Source: Self-asserted source
Zizi Elsisi via Europe PubMed Central

Peer review (1 review for 1 publication/grant)

Review activity for PloS one. (1)